Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

[Anti-mycobacteria drugs therapy for periductal mastitis with fistula].

Yu HJ, Wang Q, Yang JM, Lian ZQ, Zhang AQ, Li WP, Xu J, Zhu CX, Gao HY, Lai YX.

Zhonghua Wai Ke Za Zhi. 2012 Nov;50(11):971-4. Chinese.

PMID:
23302478
2.
3.
4.

[Tuberculosis of the breast].

Cuervo SI, Bonilla DA, Murcia MI, Hernández J, Gómez JC.

Biomedica. 2013 Jan-Mar;33(1):36-41. doi: 10.1590/S0120-41572013000100005. Spanish.

5.

[Bilateral tuberculous mastitis nulliparous patient, initially treated as idiopathic granulomatous mastitis].

Ruiz-Moreno JL, Peña-Santos G.

Ginecol Obstet Mex. 2012 Mar;80(3):228-31. Spanish.

PMID:
22812180
6.

Periductal mastitis. Clinical characteristics and outcome.

Ammari FF, Yaghan RJ, Omari AK.

Saudi Med J. 2002 Jul;23(7):819-22.

PMID:
12174233
7.

Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis.

Al Jarad N, Demertzis P, Jones DJ, Barnes NC, Rudd RM, Gaya H, Wedzicha JA, Hughes DT, Empey DW.

Thorax. 1996 Feb;51(2):137-9.

9.

Diagnosis and treatment of cervical tuberculous lymphadenitis.

Weiler Z, Nelly P, Baruchin AM, Oren S.

J Oral Maxillofac Surg. 2000 May;58(5):477-81.

PMID:
10800901
10.

Tuberculosis of the breast.

Göksoy E, Düren M, Durgun V, Uygun N.

Eur J Surg. 1995 Jul;161(7):471-3.

PMID:
7488659
11.

Treatment of nontuberculous mycobacterial infections in pediatric patients.

Levin RH, Bolinger AM.

Clin Pharm. 1988 Jul;7(7):545-51.

PMID:
2843317
12.

[Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].

Brändli O, Haegi V, Villiger B, Bohn W, Baumann HR, Zäch R.

Schweiz Med Wochenschr. 1989 Mar 11;119(10):299-305. German.

PMID:
2652281
13.

Successfully treated Mycobacterium abscessus mastitis: a rare cause of breast masses.

Yasar KK, Pehlivanoglu F, Sengoz G, Cabioglu N.

Indian J Med Microbiol. 2011 Oct-Dec;29(4):425-7. doi: 10.4103/0255-0857.90187.

14.

The clearance of theophylline is increased during the initial period of tuberculosis treatment.

Ahn HC, Lee YC.

Int J Tuberc Lung Dis. 2003 Jun;7(6):587-91.

PMID:
12797703
15.

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Park SK, Kim JH, Kang H, Cho JS, Smego RA Jr.

Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.

16.

Isoniazid- and streptomycin-resistant miliary tuberculosis complicated by intracranial tuberculoma in a Japanese infant.

Ishiwada N, Tokunaga O, Nagasawa K, Ichimoto K, Kinoshita K, Hishiki H, Kohno Y.

Tohoku J Exp Med. 2013 Mar;229(3):221-5.

17.

[Procedure in case of suspected mycobacterial infection of lymph nodes of the neck. 2. Therapy].

Göpel B, Götte K.

Laryngorhinootologie. 2005 Aug;84(8):610-9; quiz 621-2. Review. German.

PMID:
16080064
18.

Pharmacokinetics of first-line tuberculosis drugs in Tanzanian patients.

Tostmann A, Mtabho CM, Semvua HH, van den Boogaard J, Kibiki GS, Boeree MJ, Aarnoutse RE.

Antimicrob Agents Chemother. 2013 Jul;57(7):3208-13. doi: 10.1128/AAC.02599-12. Epub 2013 Apr 29.

19.

[Epidural abscess due to a Mycobacterium tuberculosis strain with primary resistance to isoniazid and ethambutol].

Sener A, Akçalı A, Karatağ O, Koşar S, Değirmenci Y, Akman T.

Mikrobiyol Bul. 2012 Oct;46(4):689-94. Turkish.

PMID:
23188583
20.

Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons.

Sterling TR, Alwood K, Gachuhi R, Coggin W, Blazes D, Bishai WR, Chaisson RE.

AIDS. 1999 Oct 1;13(14):1899-904.

PMID:
10513648

Supplemental Content

Support Center